Development of peptide 3D structure mimetics: Rational design of novel peptoid cholecystokinin receptor antagonists

Journal of Medicinal Chemistry

Volumn 43, Issue 19, 2000, Pages 3505-3517

  Low, C M R ^a   Black, J W ^a   Broughton, H B ^a   Buck, I M ^a   Davies, J M R ^a   Dunstone, D J ^a   Hull, R A D ^a   Kalindjian, S B ^a   McDonald, I M ^a   Pether, M J ^a   Shankley, N P ^a   Steel, K I M ^a  

^a James Black Foundation   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; GASTRIN; GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND; N (SUCCINYL DEXTRO ASPARTYL 2 PHENYLETHYLAMIDO)TRYPTOPHYL 2 (2 NAPHTHYL)ETHYLAMIDE; N TERT BENZYLOXYCARBONYL TRYPTOPHYL 2 NAPHTHYLALANINE ASPARTYL 2 PHENYLETHYLAMIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; ENANTIOMER; HYBRIDIZATION; HYDROGEN BOND; HYDROPHOBICITY; ISOMERISM; LIGAND BINDING; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; SOLITARY TRACT NUCLEUS;

ANIMALS; BINDING, COMPETITIVE; CEREBRAL CORTEX; CHOLECYSTOKININ; GALLBLADDER; GASTRIC ACID; GUINEA PIGS; LIGANDS; MICE; MODELS, MOLECULAR; MOLECULAR MIMICRY; MUSCLE, SMOOTH; OLIGOPEPTIDES; PANCREAS; PEPTIDE FRAGMENTS; PEPTIDES; PEPTOIDS; RATS; RECEPTORS, CHOLECYSTOKININ; STEREOISOMERISM;

EID: 0034699441     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm000937a     Document Type: Article

References (53)

1. 3H-MK-329
2. Effect of the specific cholecystokinin receptor antagonist Loxiglumide on bombesin stimulated pancreatic enzyme secretion in man
3. The effect of Loxiglumide (cr-1505) on basal and bombesin-stimulated gallbladder volume in man
4. 2 Brain cholecystokinin receptors - Implications for behavioral actions
5. The human brain cholecystokinin-B gastrin receptor - Cloning and characterization
6. Molecular-cloning and functional expression of the human gallbladder cholecystokinin-A receptor
7. Molecular-cloning, functional expression, and chromosomal localization of the human cholecystokinin type-A receptor
8. Molecular-cloning, functional expression and chromosomal localization of the human cholecystokinin type-A receptor
9. Human gastrin-isolation, structure, and synthesis-isolation of two gastrins from human antral mucosa
10. Synthesis and binding affinities of analogues of cholecystokinin-(30-33) as probes for central nervous system cholecystokinin receptors
11. Is caerulein amphibian CCK?
12. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist
13. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo
14. Evidence for a physiological role for CCK in the regulation of food intake in mice
15. The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat
16. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity
17. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat
18. The ureidoacetamides, a novel family of non-peptide CCKB/Gastrin antagonists
19. Benzodiazepine gastrin and brain cholecystokinin receptor ligands - L-365,260
20. Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin
21. Diphenylpyrazolidinone and benzodiazepine cholecystokinin antagonists - A case of convergent evolution in medicinal chemistry
22. Peripheral biological activity of SR 27987: A new potent non-peptide antagonist of CCKA receptors
23. 2-Nap - A selective, hydrophilic, nonpeptide CCKA-receptor antagonist derived from the cholecystokinin C-terminal dipeptide
24. 2-Naphthalenesulphonyl L-aspartyl-(2-phenethyl)amide (2-Nap) - A selective cholecystokinin CCKA-receptor antagonist
25. Novel oxathiazinones as gastrin ligands - Unexpected products from the Schotten-Baumann reaction of arylsulfonyl chlorides with derivatives of aspartic-acid
26. A new class of nonpeptidic cholecystokinin-B gastrin receptor antagonists based on dibenzobicyclo[2.2.2]octane
27. Improving the affinity and selectivity of a nonpeptide series of cholecystokinin-B/gastrin receptor antagonists based on the dibenzobicyclo[2.2.2]octane skeleton
28. Nonpeptide cholecystokinin-B/gastrin receptor antagonists based on bicyclic heteroaromatic skeletons
29. Rationally designed 'dipeptoid' analogues of CCK α-methyltryptophan derivatives, highly selective and orally active gastrin and CCKB antagonists with potent anxiolytic properties
30. Selective ligands for cholecystokinin receptor subtypes CCK-A and CCK-B within a single structural class
31. Cholecystekinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase
32. The putative CCKB receptor antagonist CI-988 stimulated pancreatic secretion in the anaesthetized rat
33. Analysis of the agonism of PD-134308 in guinea pig gall bladder
34. Characterisation of cholecystokinin-A receptor agonist activity by a family of cholecystokinin-B receptor antagonists
35. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat
36. A new CCK-B/gastrin receptor antagonist acts an agonist on the rat pancreas
37. PD 135158, a CCKB/gastrin receptor antagonist, stimulates rat pancreatic enzyme secretion as a CCKA receptor agonist
38. Extended electron distributions applied to the molecular mechanics of some intermolecular interactions
39. Ac-[3-Alkylthioproline(31)] and Ac-[4-Alkylthioproline(31)] CCK4 analogues - Synthesis and implications for the CCK-B recepter-bound conformation
40. The isolated stomach preparation of the mouse: A physiological unit for pharmacological analysis
41. Analysis of the complex pharmacology expressed by the CCKB/gastrin-receptor ligand PD134,308 on gastric assays
42. Structure-function relationships in gastrin-like peptides
43. Structure-function relation in the active C-terminal tetrapeptide sequence of gastrin
44. Polypeptides. Part IX. Variations of the methionyl position in the c-terminal tetrapeptide amide sequence of the gastrins
45. A hierarchical approach to peptidomimetic design
46. Phenylethylamide derivatives of the C-terminal tetrapeptide of gastrin
47. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives
48. Conformational-analysis of cholecystokinin fragments CCK4, CCK5, and CCK6 by H-1-nmr spectroscopy and fluorescence-transfer measurements
49. On the biologically active structures of cholecystokinin, little gastrin and enkaphalin in the gastrointestinal system
50. Methods for drug discovery - Development of potent, selective, orally effective cholecystokinin antagonists
51. Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide lorglumide and loxiglumide in the guinea-pig gall bladder
52. Some statistical methods useful in circulation research